SCALETTI, FEDERICA
SCALETTI, FEDERICA
Chimica 'Ugo Schiff' - DICUS
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents
2012 Chiara Gabbiani; Maria Agostina Cinellu; Laura Maiore; Lara Massai; Federica Scaletti; Luigi Messori
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents
2014 Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C.
Engineering Gold Nanorods for Cancer Treatment: Biological Profile, Protein Interactions and Drug Delivery.
2016 Scaletti, Federica
Gold compounds: new anticancer drugs candidates. Studies of protein metalation processes
2012 Lara Massai; Federica Scaletti; Chiara Gabbiani; Elena Michelucci; Luigi Messori
Interactions of Gold-based drugs with proteins: crystal structure of the adduct formed between Ribonuclease A and a cytotoxic gold(III) compound
2014 Luigi Messori;Federica Scaletti;Lara Massai;Maria A. Cinellu;Irene Russo Krauss;Giovanna di Martino;Alessandro Vergara;Luigi Paduano;Antonello Merlino
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation
2015 Marzo, Tiziano; Scaletti, Federica; Michelucci, Elena; Gabbiani, Chiara; Pescitelli, Gennaro; Messori, Luigi; Massai, Lara
Mechanistic studies on cytotoxic gold compounds
2014 L Messori; L Massai; F Scaletti; T Marzo; C Gabbiani
Medicinal gold compounds form tight adducts with the copper chaperone Atox-1: biological and pharmacological implications
2012 Chiara Gabbiani; Federica Scaletti; Lara Massai; Elena Michelucci; Maria A. Cinellu; Luigi Messori
Metal-Based Compounds as Prospective Antileishmanial Agents: Inhibition of Trypanothione Reductase by Selected Gold Complexes
2013 Gianni Colotti;Andrea Ilari;Annarita Fiorillo;Paola Baiocco;Maria Agostina Cinellu;Laura Maiore;Federica Scaletti;Chiara Gabbiani;Luigi Messori
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels
2014 S Pillozzi; L Gasparoli; M Stefanini; M Ristori; M D'Amico; E Alessio; F Scaletti; A Becchetti; A Arcangeli; L Messori
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules
2019 Savic A.; Marzo T.; Scaletti F.; Massai L.; Bartoli G.; Hoogenboom R.; Messori L.; Van Deun R.; Van Hecke K.
Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme
2012 Chiara Gabbiani;Lara Massai;Federica Scaletti;Elena Michelucci;Laura Maiore;Maria Agostina Cinellu; Luigi Messori
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.)
2014 Gamberi T; Massai L; Magherini F; Landini I; Fiaschi T; Scaletti F; Gabbiani C; Bianchi L; Bini L; Nobili S; Perrone G; Mini E; Messori L; Modesti A
Rapid purification of gold nanorods for biomedical applications
2014 Federica Scaletti; Chang Soo Kim; Luigi Messori; Vincent M. Rotello
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin
2015 Farivash Darabi; Tiziano Marzo; Lara Massai; Federica Scaletti; Elena Michelucci; Luigi Messori
Ru(CO)x-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo
2017 Tamasi, Gabriella*; Merlino, Antonello; Scaletti, Federica; Heffeter, Petra; Legin, Anton A.; Jakupec, Michael A.; Berger, Walter; Messori, Luigi; Keppler, Bernhard K.; Cini, Renzo
Size dependent biological profiles of PEGylated gold nanorods
2014 Francesca Tatini;Ida Landini;Federica Scaletti;Lara Massai;Sonia Centi;Fulvio Ratto;Stefania Nobili;Giovanni Romano;Franco Fusi;Luigi Messori;Enrico Mini;Roberto Pini
Studies of cytotoxic gold compounds: interactions with model proteins and with the copper chaperone Atox-1
2012 Lara Massai; Federica Scaletti; Chiara Gabbiani; Elena Michelucci; Luigi Messori
The fate of differently functionalized gold nanorods in human serum: A response from capillary electrophoresisâinductively coupled plasma mass spectrometry
2017 Matczuk, Magdalena*; Legat, Joanna; Scaletti, Federica; Messori, Luigi; Timerbaev, Andrei R.; Jarosz, Maciej
The mode of action of anticancer gold-based drugs: a structural perspective
2013 Luigi Messori;Federica Scaletti;Lara Massai;Maria A. Cinellu;Chiara Gabbiani;Alessandro Vergara;Antonello Merlino
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents | 2012 | Chiara Gabbiani; Maria Agostina Cinellu; Laura Maiore; Lara Massai; Federica Scaletti; Luigi Messori | |
| Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents | 2014 | Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C. | |
| Engineering Gold Nanorods for Cancer Treatment: Biological Profile, Protein Interactions and Drug Delivery. | 2016 | Scaletti, Federica | |
| Gold compounds: new anticancer drugs candidates. Studies of protein metalation processes | 2012 | Lara Massai; Federica Scaletti; Chiara Gabbiani; Elena Michelucci; Luigi Messori | |
| Interactions of Gold-based drugs with proteins: crystal structure of the adduct formed between Ribonuclease A and a cytotoxic gold(III) compound | 2014 | Luigi Messori;Federica Scaletti;Lara Massai;Maria A. Cinellu;Irene Russo Krauss;Giovanna di Martino;Alessandro Vergara;Luigi Paduano;Antonello Merlino | |
| Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation | 2015 | Marzo, Tiziano; Scaletti, Federica; Michelucci, Elena; Gabbiani, Chiara; Pescitelli, Gennaro; Messori, Luigi; Massai, Lara | |
| Mechanistic studies on cytotoxic gold compounds | 2014 | L Messori; L Massai; F Scaletti; T Marzo; C Gabbiani | |
| Medicinal gold compounds form tight adducts with the copper chaperone Atox-1: biological and pharmacological implications | 2012 | Chiara Gabbiani; Federica Scaletti; Lara Massai; Elena Michelucci; Maria A. Cinellu; Luigi Messori | |
| Metal-Based Compounds as Prospective Antileishmanial Agents: Inhibition of Trypanothione Reductase by Selected Gold Complexes | 2013 | Gianni Colotti;Andrea Ilari;Annarita Fiorillo;Paola Baiocco;Maria Agostina Cinellu;Laura Maiore;Federica Scaletti;Chiara Gabbiani;Luigi Messori | |
| NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels | 2014 | S Pillozzi; L Gasparoli; M Stefanini; M Ristori; M D'Amico; E Alessio; F Scaletti; A Becchetti; A Arcangeli; L Messori | |
| New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules | 2019 | Savic A.; Marzo T.; Scaletti F.; Massai L.; Bartoli G.; Hoogenboom R.; Messori L.; Van Deun R.; Van Hecke K. | |
| Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme | 2012 | Chiara Gabbiani;Lara Massai;Federica Scaletti;Elena Michelucci;Laura Maiore;Maria Agostina Cinellu; Luigi Messori | |
| Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) | 2014 | Gamberi T; Massai L; Magherini F; Landini I; Fiaschi T; Scaletti F; Gabbiani C; Bianchi L; Bini L; Nobili S; Perrone G; Mini E; Messori L; Modesti A | |
| Rapid purification of gold nanorods for biomedical applications | 2014 | Federica Scaletti; Chang Soo Kim; Luigi Messori; Vincent M. Rotello | |
| Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin | 2015 | Farivash Darabi; Tiziano Marzo; Lara Massai; Federica Scaletti; Elena Michelucci; Luigi Messori | |
| Ru(CO)x-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo | 2017 | Tamasi, Gabriella*; Merlino, Antonello; Scaletti, Federica; Heffeter, Petra; Legin, Anton A.; Jakupec, Michael A.; Berger, Walter; Messori, Luigi; Keppler, Bernhard K.; Cini, Renzo | |
| Size dependent biological profiles of PEGylated gold nanorods | 2014 | Francesca Tatini;Ida Landini;Federica Scaletti;Lara Massai;Sonia Centi;Fulvio Ratto;Stefania Nobili;Giovanni Romano;Franco Fusi;Luigi Messori;Enrico Mini;Roberto Pini | |
| Studies of cytotoxic gold compounds: interactions with model proteins and with the copper chaperone Atox-1 | 2012 | Lara Massai; Federica Scaletti; Chiara Gabbiani; Elena Michelucci; Luigi Messori | |
| The fate of differently functionalized gold nanorods in human serum: A response from capillary electrophoresisâinductively coupled plasma mass spectrometry | 2017 | Matczuk, Magdalena*; Legat, Joanna; Scaletti, Federica; Messori, Luigi; Timerbaev, Andrei R.; Jarosz, Maciej | |
| The mode of action of anticancer gold-based drugs: a structural perspective | 2013 | Luigi Messori;Federica Scaletti;Lara Massai;Maria A. Cinellu;Chiara Gabbiani;Alessandro Vergara;Antonello Merlino |